IQVIA CFO Ron Bruehlman to Speak at Jefferies Healthcare Conference on June 10, 2022

Rhea-AI Summary

IQVIA Holdings Inc. (NYSE:IQV) will have CFO Ron Bruehlman speak at the Jefferies Healthcare Conference in New York City on Friday, June 10, 2022, at 11:30 a.m. ET. A live audio webcast of the presentation will be accessible on the IQVIA Investor Relations website, with a replay available later that day. IQVIA is a global leader in advanced analytics, technology solutions, and clinical research services for life sciences, operating in over 100 countries with approximately 82,000 employees. The company emphasizes patient privacy and utilizes various technologies to enhance healthcare outcomes.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Jefferies Healthcare Conference in New York City on Friday, June 10, 2022 at 11:30 a.m. ET.

A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

IQVIAFIN

View source version on businesswire.com: https://www.businesswire.com/news/home/20220525006003/en/

Nick Childs, IQVIA Investor Relations (nicholas.childs@iqvia.com)

+1.973.316.3828



Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com)

+1.484.567.6732

Source: IQVIA Holdings Inc.

FAQ

What date is the IQVIA presentation at the Jefferies Healthcare Conference?

The IQVIA presentation at the Jefferies Healthcare Conference is on Friday, June 10, 2022.

Who will represent IQVIA at the Jefferies Healthcare Conference?

CFO Ron Bruehlman will represent IQVIA at the Jefferies Healthcare Conference.

Where can I access the live webcast of the IQVIA presentation?

You can access the live webcast of the IQVIA presentation on their Investor Relations website.

What is the primary focus of IQVIA?

IQVIA focuses on advanced analytics, technology solutions, and clinical research services for the life sciences industry.

How many employees does IQVIA have?

IQVIA has approximately 82,000 employees.